About This Study
The purpose of this study is to learn how safe and effective a new study medicine called TORL-1-23 is for people with advanced ovarian cancer that has a tumor marker called Claudin-6. Researchers want to see if the medicine can help slow cancer growth or shrink tumors and learn more about its side effects.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- Use of Study Health Plans
- Review of Medical History
- Physical Examinations
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 18 - 100+ years old
- Female
Language
- This study enrolls English and Spanish speakers
Additional Study Information
- Compensation Offered
- Reimbursement offered
Study Locations
- Greater Charlotte, NC